1. Market Research
  2. > Chronic Disease Industry

rheumatoid arthritis Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Arthritis, Infectious Disease, Autoimmune Disease, Diagnostics, Biosimilar, Injectable Delivery, Anti Rheumatic, Pharmaceutical, Monoclonal Antibody, Prosthesis, Analgesic, Eye Disease, Chronic Pain, Musculoskeletal Disorder, Orthopedic Prosthesis, Prefillable Syringe, Protein, Stem Cell, Immunomodulator.


 
1-10 of 63 reports for rheumatoid arthritis

Purchase Reports From Reputable Market Research Publishers

Rheumatoid Arthritis (RA) - Epidemiology Forecast To 2023

Rheumatoid Arthritis (RA) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Rheumatoid Arthritis (RA) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Rheumatoid Arthritis (RA) in seven major markets (US, France, Germany, Italy, ...

 Juvenile Rheumatoid Arthritis-Pipeline Insights, 2017

Juvenile Rheumatoid Arthritis-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Juvenile Rheumatoid Arthritis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Juvenile Rheumatoid ...

Rheumatoid Arthritis - Pipeline Review, H2 2016

Rheumatoid Arthritis - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides ...

Prefilled Syringes Market Analysis By Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, Vaccines, Hormone Replacement), By Distribution Channel (Hospitals, Mail Order Pharmacies, Ambulatory Surgery Centers), And Segment Forecasts, 2014 - 2025

Prefilled Syringes Market Analysis By Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, Vaccines, Hormone Replacement), By Distribution Channel (Hospitals, Mail Order Pharmacies, Ambulatory Surgery Centers), And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • December 2016
  • by Grand View Research

The global prefilled syringes market size is expected to reach USD 22.5 Billion by 2025, according to a new study by Grand View Research, Inc. Key factors driving the market expansion include technological ...

Prefilled Syringes Market Analysis By Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, Vaccines, Hormone Replacement), By Distribution Channel (Hospitals, Mail Order Pharmacies, Ambulatory Surgery Centers), And Segment Forecasts, 2014-2025

Prefilled Syringes Market Analysis By Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, Vaccines, Hormone Replacement), By Distribution Channel (Hospitals, Mail Order Pharmacies, Ambulatory Surgery Centers), And Segment Forecasts, 2014-2025

  • $ 4950
  • Industry report
  • December 2016
  • by Grand View Research

The global prefilled syringes market size is expected to reach USD 22.5 Billion by 2025, according to a new study by Grand View Research, Inc. Key factors driving the market expansion include technological ...

Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016 - 2026

Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016 - 2026

  • $ 2349
  • Industry report
  • November 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Rheumatoid Arthritis (RA) is an autoimmune, inflammatory disorder wherein various components of the immune system begin to attack the body’s own cells and tissues. The disease is characterized ...

U.S. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market (Ankylosing Spondylitis, Alopecia Areata, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Psoriasis) By Technology Report, 2013 - 2024

U.S. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market (Ankylosing Spondylitis, Alopecia Areata, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Psoriasis) By Technology Report, 2013 - 2024

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The U.S. IVD for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach a value of USD 4.74 billion by 2024 .The U.S. Laboratory Developed Test (LDT) for autoimmune diseases ...

Global Rheumatoid Arthritis Partnering 2010 to 2016

Global Rheumatoid Arthritis Partnering 2010 to 2016

  • $ 1495
  • Industry report
  • November 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - ...

Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rheumatoid Arthritis in 17 Major Markets Rheumatoid arthritis (RA) is classified as an autoimmune disease and occurs when the immune ...

NPS+ Rheumatoid Arthritis (EU5)

NPS+ Rheumatoid Arthritis (EU5)

  • $ 2668
  • Industry report
  • September 2016
  • by Firstword Pharma

Two leading brands continue to dominate satisfaction scores. Where does your brand rank? Few brands are earning high satisfaction scores in the European rheumatoid arthritis (RA) treatment market, but ...

About 5000 reports for rheumatoid arthritis

Download Unlimited Documents from Trusted Public Sources

Healthcare Industry - Company Report, 2015

  • January 2015
    218 pages
  • Stroke  

    Arthritis  

    Hospital  

  • Netherlands  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.